Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes

Sanna Pikkusaari; Manuela Tumiati; Anni Virtanen; Jaana Oikkonen; Yilin Li; Fernando Perez-Villatoro; Taru Muranen; Matilda Salko; Kaisa Huhtinen; Anna Kanerva; Heidi Koskela; Johanna Tapper; Riitta Koivisto-Korander; Titta Joutsiniemi; Ulla-Maija Haltia; Heini Lassus; Sampsa Hautaniemi; Anniina Färkkilä; Johanna Hynninen; Sakari Hietanen; Olli Carpen; Liisa Kauppi

doi:10.1158/1078-0432.CCR-22-3156

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes

Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Perez-Villatoro, Taru Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Färkkilä, Johanna Hynninen, Sakari HietanenOlli Carpen, Liisa Kauppi

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Clinical Cancer Research
Volym	29
Nummer	16
Sidor (från-till)	3110-3123
Antal sidor	14
ISSN	1078-0432
DOI	https://doi.org/10.1158/1078-0432.CCR-22-3156
Status	Publicerad - 15 aug. 2023
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1158/1078-0432.CCR-22-3156

ccr-22-3156Slutlig publicerad version, 5,62 MBLicens: CC BY

Discovery and therapeutic exploitation of immunological vulnerabilities in ovarian cancer
Färkkilä, A. (Projektledare), Kang, Z. (Deltagare), Niemiec, I. (Deltagare), Nagaraj, A. (Deltagare), Perez Villatoro, F. R. (Deltagare), Chernenko, A. (Deltagare) & Shah, S. (Deltagare)
01/01/2021 → 31/12/2023
Projekt: Helsingfors Universitetets treåriga forskningsprojekt

iCAN Ovarian Cancer Subproject coordinator
Färkkilä, A. (Deltagare)
2021 → …
Aktivitet: Andra aktivitetstyper › Annan

Citera det här

Pikkusaari, S., Tumiati, M., Virtanen, A., Oikkonen, J., Li, Y., Perez-Villatoro, F., Muranen, T., Salko, M., Huhtinen, K., Kanerva, A., Koskela, H., Tapper, J., Koivisto-Korander, R., Joutsiniemi, T., Haltia, U.-M., Lassus, H., Hautaniemi, S., Färkkilä, A., Hynninen, J., ... Kauppi, L. (2023). Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes. Clinical Cancer Research, 29(16), 3110-3123. https://doi.org/10.1158/1078-0432.CCR-22-3156

@article{8a24e36706054f31991c1536d6f7cf5e,

title = "Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes",

keywords = "Somatic mutations, Double-blind, Platinum, Deficiency, Maintenance, Tumors, Therapy, Recommendations, Identification, Chemotherapy, 3122 Cancers",

author = "Sanna Pikkusaari and Manuela Tumiati and Anni Virtanen and Jaana Oikkonen and Yilin Li and Fernando Perez-Villatoro and Taru Muranen and Matilda Salko and Kaisa Huhtinen and Anna Kanerva and Heidi Koskela and Johanna Tapper and Riitta Koivisto-Korander and Titta Joutsiniemi and Ulla-Maija Haltia and Heini Lassus and Sampsa Hautaniemi and Anniina F{\"a}rkkil{\"a} and Johanna Hynninen and Sakari Hietanen and Olli Carpen and Liisa Kauppi",

year = "2023",

month = aug,

day = "15",

doi = "10.1158/1078-0432.CCR-22-3156",

language = "English",

volume = "29",

pages = "3110--3123",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "16",

}

Pikkusaari, S, Tumiati, M, Virtanen, A , Oikkonen, J, Li, Y, Perez-Villatoro, F , Muranen, T , Salko, M, Huhtinen, K, Kanerva, A, Koskela, H, Tapper, J, Koivisto-Korander, R, Joutsiniemi, T, Haltia, U-M, Lassus, H, Hautaniemi, S , Färkkilä, A, Hynninen, J, Hietanen, S, Carpen, O & Kauppi, L 2023, 'Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes', Clinical Cancer Research, vol. 29, nr. 16, s. 3110-3123. https://doi.org/10.1158/1078-0432.CCR-22-3156

TY - JOUR

T1 - Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes

AU - Pikkusaari, Sanna

AU - Tumiati, Manuela

AU - Virtanen, Anni

AU - Oikkonen, Jaana

AU - Li, Yilin

AU - Perez-Villatoro, Fernando

AU - Muranen, Taru

AU - Salko, Matilda

AU - Huhtinen, Kaisa

AU - Kanerva, Anna

AU - Koskela, Heidi

AU - Tapper, Johanna

AU - Koivisto-Korander, Riitta

AU - Joutsiniemi, Titta

AU - Haltia, Ulla-Maija

AU - Lassus, Heini

AU - Hautaniemi, Sampsa

AU - Färkkilä, Anniina

AU - Hynninen, Johanna

AU - Hietanen, Sakari

AU - Carpen, Olli

AU - Kauppi, Liisa

PY - 2023/8/15

Y1 - 2023/8/15

KW - Somatic mutations

KW - Double-blind

KW - Platinum

KW - Deficiency

KW - Maintenance

KW - Tumors

KW - Therapy

KW - Recommendations

KW - Identification

KW - Chemotherapy

KW - 3122 Cancers

U2 - 10.1158/1078-0432.CCR-22-3156

DO - 10.1158/1078-0432.CCR-22-3156

M3 - Article

C2 - 36805632

SN - 1078-0432

VL - 29

SP - 3110

EP - 3123

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 16

ER -

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes

Vetenskapsgrenar

Åtkomst av dokument

Projekt

Discovery and therapeutic exploitation of immunological vulnerabilities in ovarian cancer

Aktiviteter

iCAN Ovarian Cancer Subproject coordinator

Citera det här